Free Radical Formation by Cytotoxic Alkylaminoanthraquinones in Liver Microsomes

  • Laurence H. Patterson
  • Jaspal Basra
  • Jeffrey R. Brown
Part of the Basic Life Sciences book series (BLSC, volume 49)


The anthracycline antibiotics as exemplified by doxorubicin and daunorubicin are widely used antitumour agents. The mechanism of toxicity of these agents probably involves damage to multiple sites within cell systems since DNA binding, DNA strand breakage, enzyme inactivation, and membrane effects have all been described.1 The planar chromophore and cationic nature of the clinically important anthracyclines are essential to many of their interactions with biological systems especially intercalative binding to DNA2 and free radical generation.3 Mitozantrone is an alkylaminoanthraquinone antitumour agent which has been developed from a consideration of the modes of action of the anthracyclines and although a more simplified derivative it has a similar activity with respect to DNA binding4 and also generates free radicals.5 To explore further the structural factors influencing DNA binding and free radical generation by alkylaminoanthraquinones we have prepared derivatives based on the anthraquinone chromophore.6 In this study metabolic free radical generation by four alkylaminoanthraquinones (compounds 1–4) that differ in the substitution pattern is described (Figure 1).


Electron Spin Resonance Electron Spin Resonance Spectrum Free Radical Generation Free Radical Formation NADPH Oxidation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. Gianni, B. L. Gorden, and C.E. Meyers, The biochemical basis of anthracycline toxicity and antitumour activity, in “Reviews in Biochemical Toxicity, Vol. 5”, E. Philpot and E. Bend, eds, Elsevier, New York (1984).Google Scholar
  2. 2.
    J. R. Brown and S. H. Imam, Recent studies on doxorubicin and its analogues, Prog. Med. Chem. 21:169 (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    B. Kalyanaraman, E. Perez-Reyes, and R. P. Mason, Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs, Biochim. Biophys. Acta 630:119 (1980).PubMedCrossRefGoogle Scholar
  4. 4.
    F. Traganos, Dihydroxyanthraquinone and related Bis (substituted)-aminoanthraquinones: a novel class of antitumour agent. Pharmacol. Ther. 22:199 (1983).PubMedCrossRefGoogle Scholar
  5. 5.
    J. Basra, C. R. Wolf, J. R. Brown, and L. H. Patterson, Evidence for human liver mediated free-radical formation by doxorubicin and mitozantrone, Anti-Cancer Drug Design 1:45 (1985).PubMedGoogle Scholar
  6. 6.
    S. A. Islam, S. Neidle, B. M. Gandecha, M. B. Partridge, and L.H. Patterson, Comparative computer graphics and solution studies on the DNA interaction of substituted anthraquinones based on doxorubicin and mitoxantrone, J. Med. Chem. 28:857 (1985).PubMedCrossRefGoogle Scholar
  7. 7.
    R. P. Mason and C. F. Chignell, Free radicals in pharmacology and toxicology: selected topics, Pharmacol. Rev. 31:189 (1982).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Laurence H. Patterson
    • 1
  • Jaspal Basra
    • 1
  • Jeffrey R. Brown
    • 2
  1. 1.Department of Pharmaceutical Chemistry, School of PharmacyLeicester PolytechnicLeicesterUK
  2. 2.Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical SciencesSunderland PolytechnicSunderlandUK

Personalised recommendations